KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹51 Cr | ₹27 Cr | ₹61 Cr | ₹62 Cr | ₹21 Cr |
What is the latest Consolidated Net Profit of KOPRAN ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹51 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹21 Cr |
How is Consolidated Net Profit of KOPRAN Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹51 Cr | 87.11 | |
| Mar2024 | ₹27 Cr | -55.38 | |
| Mar2023 | ₹61 Cr | -0.93 | |
| Mar2022 | ₹62 Cr | 193.08 | |
| Mar2021 | ₹21 Cr | - | |
Compare Consolidated Net Profit of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹593.8 Cr | -6.5% | -10.8% | -26.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -6.5% |
-10.8% |
-26.6% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses